Jonathan Ayre represents clients across the energy spectrum including oil and gas, renewable power, and chemical industry companies and their investors in acquisitions, divestitures, joint ventures, project development, financing and restructuring transactions.
Jonathan's recent experience includes representing note purchasers in securitizations of operated and non-operated oil and gas wellbore working interests with an aggregate value exceeding $6 billion. In addition to representing the note purchasers on the initial securitization of non-operated working interests, he has closed the first transactions that included operated working interests, overriding royalty interests, portfolios of primarily BLM leases, portfolios including tribal lands, and midstream gathering systems, and the first joint 144A / 4(a)(2) offering. Jonathan also has significant experience representing companies driving the energy transition, including representing project developers in connection with engineering, procurement and construction agreements, solar module purchase agreements, transformer purchase agreements, and operation and maintenance agreements.
Chambers Global has reported, "He knows the industry very well and takes a commercial approach to help resolve differences with the counterparty. He has a good bedside manner and cooperates well with others,” and ”he's very resourceful and he approaches the oil and gas and corporate sector with a true business sense." Jonathan also was recognized in 2020 by Law 360 as an Energy Rising Star.
Jonathan is an active supporter of the Houston Symphony, serving as Chairman of the Houston Symphony's Finance Committee, as a Governing Director on the Houston Symphony Society's Board of Trustees, and as chair of the 2021 Houston Symphony's Wine Dinner and Collector's Auction. He serves as a member of the Steering Committee of the Houston Men of Distinction Annual Awards Luncheon, an organization that recognizes Houston men who have distinguished themselves through excellence in community achievement, thereby providing support in superior biomedical research, education, and patient care in the Texas Medical Center.